In vitro and in vivo activation induces BAFF and APRIL expression in B cells

被引:106
作者
Chu, Van Trung
Enghard, Philipp
Riemekasten, Gabriela
Berek, Claudia
机构
[1] Deutsches Rheuma ForschungsZentrum, Berlin, Germany
[2] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
关键词
D O I
10.4049/jimmunol.179.9.5947
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cell-activating factor (BA.FF) and a proliferation-inducing ligand (APRIL) play key roles in peripheral B cell survival, maturation, and differentiation. BAFF and APRIL are produced by a variety of cell types such as macrophages/monocytes and dendritic cells. Our analysis shows that BAFF mRNA is also expressed in all B cell subsets isolated from bone marrow, spleen, and peritoneal cavity of BALB/c mice. APRIL expression is restricted to early stages of B cell development in the bone marrow and the peritoneal B1 subset. Stimulation of B2 and B1 cells with LPS or CpG-oligodeoxynucleotides induced MyD88-dependent plasma cell differentiation and intracellular expression of BAFF and APRIL. Furthermore, activation of B cells up-regulated membrane expression of BAFF. The finding that in vitro activation of B cells is inhibited by the antagonist transmembrane activator and calcium modulator ligand interactor Ig, indicates that BAFF and/or APRIL are released into the culture supernatants. It shows that B cell survival, proliferation, and differentiation are supported by an autocrine pathway. In vivo activation of B cells with a T-dependent Ag- induced BAFF expression in germinal center B cells. In (NZB X NZW)F, mice with established autoimmune disease, marginal zone, germinal center B cells, as well as splenic plasma cells expressed high levels of BAFF. In (NZB X NZW)F-1 mice, the continuous activation of B cells and thus overexpression of BAFF and APRIL may contribute to the development of autoimmune disease.
引用
收藏
页码:5947 / 5957
页数:11
相关论文
共 41 条
[21]   Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival [J].
Novak, AJ ;
Bram, RJ ;
Kay, NE ;
Jelinek, DF .
BLOOD, 2002, 100 (08) :2973-2979
[22]   Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling deficient mice [J].
Rahman, ZSM ;
Rao, SP ;
Kalled, SL ;
Manser, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (08) :1157-1169
[23]  
Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO
[24]  
2-5
[25]   BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases [J].
Roschke, V ;
Sosnovtseva, S ;
Ward, CD ;
Hong, JS ;
Smith, R ;
Albert, V ;
Stohl, W ;
Baker, KP ;
Ullrich, S ;
Nardelli, B ;
Hilbert, DM ;
Migone, TS .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4314-4321
[26]   G-CSF-stimulated neutrophils are a prominent source of functional BLyS [J].
Scapini, P ;
Nardelli, B ;
Nadali, G ;
Calzetti, F ;
Pizzolo, G ;
Montecucco, C ;
Cassatella, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (03) :297-302
[27]   An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway [J].
Schiemann, B ;
Gommerman, JL ;
Vora, K ;
Cachero, TG ;
Shulga-Morskaya, S ;
Dobles, M ;
Frew, E ;
Scott, ML .
SCIENCE, 2001, 293 (5537) :2111-2114
[28]   BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth [J].
Schneider, P ;
MacKay, F ;
Steiner, V ;
Hofmann, K ;
Bodmer, JL ;
Holler, N ;
Ambrose, C ;
Lawton, P ;
Bixler, S ;
Acha-Orbea, H ;
Valmori, D ;
Romero, P ;
Werner-Favre, C ;
Zubler, RH ;
Browning, JL ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1747-1756
[29]   BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus [J].
Stohl, W ;
Xu, D ;
Kim, KS ;
Koss, MN ;
Jorgensen, TN ;
Deocharan, B ;
Metzger, TE ;
Bixler, SA ;
Hong, YS ;
Ambrose, CM ;
Mackay, F ;
Morel, L ;
Putterman, C ;
Kotzin, BL ;
Kalled, SL .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2080-2091
[30]   Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis [J].
Tan, SM ;
Xu, D ;
Roschke, V ;
Perry, JW ;
Arkfeld, DG ;
Ehresmann, GR ;
Migone, TS ;
Hilbert, DA ;
Stohl, W .
ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :982-992